Hosted on MSN18h
Global influenza vaccine market to hit $14b by 2032Developments include cell-based and recombinant DNA technologies. The global influenza vaccine market is projected to cross $14b by 2032, according to DelveInsight. The sector’s expansion is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback